作者: Tetsuro Kikuchi , Tsuyoshi Hirose , Taro Iwamoto
DOI:
关键词:
摘要: The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) serotonin reuptake inhibitor in pharmaceutically acceptable carrier. may be aripiprazole or metabolite thereof, which is dopamine-serotonin system stabilizer. fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline escitalopram. useful for treating patients with mood disorders, particularly depression major depressive disorder.